ONCOSTATIN M RECEPTOR ANTIGEN BINDING PROTEINS

The invention provides anti-oncostatin M receptor-² (OSMR) antigen binding proteins, e.g., antibodies and functional fragments, derivatives, muteins, and variants thereof. OSMR antigen binding proteins interfere with binding of OSM and/or IL-31 to OSMR. In some embodiments, anti-OSMR antigen binding...

Full description

Saved in:
Bibliographic Details
Main Authors KING, Chadwick T, WEINREB, Paul H, ARNETT, Heather A, ESCOBAR, Sabine S, NARAYANAN, Saravanakumar, LIM, Ai Ching, PEDERSON, Nels E
Format Patent
LanguageEnglish
French
German
Published 20.03.2019
Subjects
CHEMISTRY
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
Online AccessGet full text

Cover

Abstract The invention provides anti-oncostatin M receptor-² (OSMR) antigen binding proteins, e.g., antibodies and functional fragments, derivatives, muteins, and variants thereof. OSMR antigen binding proteins interfere with binding of OSM and/or IL-31 to OSMR. In some embodiments, anti-OSMR antigen binding proteins are useful tools in studying diseases and disorders associated with OSMR and are particularly useful in methods of treating diseases and disorders associated with OSMR and binding of OSM and/or IL-31 to OSMR.
AbstractList The invention provides anti-oncostatin M receptor-² (OSMR) antigen binding proteins, e.g., antibodies and functional fragments, derivatives, muteins, and variants thereof. OSMR antigen binding proteins interfere with binding of OSM and/or IL-31 to OSMR. In some embodiments, anti-OSMR antigen binding proteins are useful tools in studying diseases and disorders associated with OSMR and are particularly useful in methods of treating diseases and disorders associated with OSMR and binding of OSM and/or IL-31 to OSMR.
Author LIM, Ai Ching
WEINREB, Paul H
ARNETT, Heather A
KING, Chadwick T
PEDERSON, Nels E
ESCOBAR, Sabine S
NARAYANAN, Saravanakumar
Author_xml – fullname: KING, Chadwick T
– fullname: WEINREB, Paul H
– fullname: ARNETT, Heather A
– fullname: ESCOBAR, Sabine S
– fullname: NARAYANAN, Saravanakumar
– fullname: LIM, Ai Ching
– fullname: PEDERSON, Nels E
BookMark eNrjYmDJy89L5WTQ8_dz9g8OcQzx9FPwVQhydXYNCPEPUnD0C_F0d_VTcPL0c_H0c1cICPIPcfX0C-ZhYE1LzClO5YXS3AwKbq4hzh66qQX58anFBYnJqXmpJfGuAcYmpmbmJsaOhsZEKAEAmvwnQw
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate ONCOSTATIN-M-REZEPTOR-ANTIGENBINDENDE PROTEINE
PROTÉINES DE LIAISON À L'ANTIGÈNE DU RÉCEPTEUR DE L'ONCOSTATINE M
ExternalDocumentID EP3456743A1
GroupedDBID EVB
ID FETCH-epo_espacenet_EP3456743A13
IEDL.DBID EVB
IngestDate Fri Nov 01 05:46:57 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
German
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_EP3456743A13
Notes Application Number: EP20180185359
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190320&DB=EPODOC&CC=EP&NR=3456743A1
ParticipantIDs epo_espacenet_EP3456743A1
PublicationCentury 2000
PublicationDate 20190320
PublicationDateYYYYMMDD 2019-03-20
PublicationDate_xml – month: 03
  year: 2019
  text: 20190320
  day: 20
PublicationDecade 2010
PublicationYear 2019
RelatedCompanies Kiniksa Pharmaceuticals, Ltd
RelatedCompanies_xml – name: Kiniksa Pharmaceuticals, Ltd
Score 3.190625
Snippet The invention provides anti-oncostatin M receptor-² (OSMR) antigen binding proteins, e.g., antibodies and functional fragments, derivatives, muteins, and...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
Title ONCOSTATIN M RECEPTOR ANTIGEN BINDING PROTEINS
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190320&DB=EPODOC&locale=&CC=EP&NR=3456743A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fS8MwED7GFPVNp-L8RR6kb9W2adf1YcjWpluFpaVG2dtoYgZ7mcNV_Pe9lm76om8hgUty8N3dl9wlAHfeG6VBoQuEeEFN11HS7KMtNhd9JQPLUQs7qKqRp7w3eXGfZt6sBcttLUz9TuhX_TgiIkoh3svaXq9_DrGiOrdy8yCX2PX-GItBZDTsGL0bdSwjGg1YlkZpaIQhtgyeo7H2qnT7IRKlPYyi_QoM7HVUFaWsf3uU-Bj2MxS2Kk-gpVcdOAy3H6914GDa3Hdjs4He5hTuU6Tfz2IoEk6mJGchy0SakyEXyZhxMkp4lPAxyfJUMGTkZ0BiJsKJiRPPd5ucs2y3RHoObeT--gJIL5AYlEjq2VK5yi_6auFQbRfaDlxtKb8L3T_FXP4zdgVHlbaqZCrHuoZ2-fGpb9C7lvK21ss3SAR6wg
link.rule.ids 230,309,783,888,25576,76882
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NT8IwFH8haMSbokb87MHsNt0nbAdiYCswZd0yq-FG1lISLkhkxn_ftwXQi96aNnltX_I-fu37ALhzZ7bt5ypHEc9t3bGk0D3Uxfrck8I3LDk3_TIbOWbt0avzNHEnNVhsc2GqOqFfVXFElCiJ8l5U-nr184gVVrGV6wexwKn3xwHvhtoGHaN1sy1DC_tdmiZhEmhBgCONZais3TLcvodAaQ89bK9sdkDf-mVSyuq3RRkcwX6KxJbFMdTUsgmNYNt4rQkH8ea_G4cb0VufwH2C8PuF93jESEwyGtCUJxnpMR4NKSP9iIURG5I0SzhFRH4KZEB5MNJx4-nuklOa7o5on0Edsb86B9L2BTolwnZNIR3ZyT05t2xl5sr0HWXITgtaf5K5-GftFhojHo-n44g9X8JhybkysMoyrqBefHyqa7S0hbipePQNMVB9sg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=ONCOSTATIN+M+RECEPTOR+ANTIGEN+BINDING+PROTEINS&rft.inventor=KING%2C+Chadwick+T&rft.inventor=WEINREB%2C+Paul+H&rft.inventor=ARNETT%2C+Heather+A&rft.inventor=ESCOBAR%2C+Sabine+S&rft.inventor=NARAYANAN%2C+Saravanakumar&rft.inventor=LIM%2C+Ai+Ching&rft.inventor=PEDERSON%2C+Nels+E&rft.date=2019-03-20&rft.externalDBID=A1&rft.externalDocID=EP3456743A1